CU-CPT9a

From Wikipedia, the free encyclopedia

CAS Number
FormulaC17H15NO2
CU-CPT9a
Identifiers
  • 4-(7-methoxyquinolin-4-yl)-2-methylphenol
CAS Number
PubChem CID
ChemSpider
Chemical and physical data
FormulaC17H15NO2
Molar mass265.312 g·mol−1
3D model (JSmol)
  • CC1=C(C=CC(=C1)C2=C3C=CC(=CC3=NC=C2)OC)O
  • InChI=1S/C17H15NO2/c1-11-9-12(3-6-17(11)19)14-7-8-18-16-10-13(20-2)4-5-15(14)16/h3-10,19H,1-2H3
  • Key:HNYBTVKYLVLWCB-UHFFFAOYSA-N

CU-CPT9a is a drug which acts as a potent and selective antagonist of Toll-like receptor 8 (TLR8), with an IC50 of 0.5nM. Activation of toll-like receptors triggers release of cytokines and other signalling factors, leading to inflammation. This is an essential part of the immune system's response to infection, but chronic activation of TLR signalling is thought to be involved in various inflammatory and autoimmune disorders. CU-CPT9a has immunosuppressant properties, and may have applications in the treatment of autoimmune disorders, as well as being used in scientific research into the function of TLR8.[1][2][3][4][5]

References

Related Articles

Wikiwand AI